- Report
- September 2025
- 250 Pages
Global
From €3915EUR$4,490USD£3,404GBP
- Report
- February 2026
- 379 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 295 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- January 2026
- 185 Pages
Global
From €3923EUR$4,500USD£3,412GBP
- Report
- June 2025
- 138 Pages
Global
From €3487EUR$3,999USD£3,032GBP
- Report
- August 2025
- 122 Pages
North America
From €3487EUR$3,999USD£3,032GBP
- Report
- January 2026
- 192 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1744EUR$2,000USD£1,516GBP
- Report
- July 2025
- 350 Pages
Global
From €4315EUR$4,949USD£3,752GBP
- Report
- August 2025
- 150 Pages
Global
From €3444EUR$3,950USD£2,995GBP
- Report
- February 2025
- 274 Pages
Global
From €4316EUR$4,950USD£3,753GBP
- Report
- January 2026
- 190 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- January 2026
- 194 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- January 2026
- 194 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- January 2026
- 188 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- August 2025
- 192 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- August 2025
- 189 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- August 2025
- 184 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- August 2025
- 192 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- August 2025
- 189 Pages
Global
From €3434EUR$3,939USD£2,986GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more